Breast tumor cells transendothelial migration induces endothelial cell anoikis through extracellular matrix degradation

Anticancer Research

Volumn 29, Issue 6, 2009, Pages 2347-2355

  Peyri, Nicole ^a   Berard, Madeleine ^a   Fauvel Lafeve, Françoise ^a   Trochon, Veronique ^c   Arbeille, Brigitte ^d   Lu, Hu ^a   Legrand, Chantal ^a   Crepin, Michel ^a,b,e  

^a SAINT LOUIS HOSPITAL   (France)

^b UNIVERSITÉ PARIS DIDEROT   (France)

^c BioAlliance Pharma   (France)

^d UNIVERSITÉ DE TOURS   (France)

^e UNIVERSITÉ PARIS 13   (France)

Author keywords

Anoikis; Apoptosis; Basement membrane degradation; Breast cancer cell; Transendothelial migration; Tumor cell intravasation

Indexed keywords

COLLAGEN TYPE 4; FIBRONECTIN; GELATINASE A; ILOMASTAT; LAMININ; TISSUE INHIBITOR OF METALLOPROTEINASE;

ANGIOGENESIS; ANOIKIS; APOPTOSIS; ARTICLE; BASEMENT MEMBRANE; BREAST CANCER; CARCINOGENESIS; CELL ADHESION; CELL CONTACT; CELL DEATH; CELL INTERACTION; CELL INVASION; CELL MEMBRANE; CELL MIGRATION; COCULTURE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DEGRADATION; ENDOTHELIUM CELL; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; FILTER; HUMAN; HUMAN CELL; NECROSIS; PRIORITY JOURNAL; PROTEIN SECRETION; TUMOR CELL; UMBILICAL VEIN;

ANOIKIS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL MOVEMENT; CELLS, CULTURED; COCULTURE TECHNIQUES; ENDOTHELIUM, VASCULAR; EXTRACELLULAR MATRIX; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASES; UMBILICAL VEINS;

EID: 67650930891     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Albini A and Sporn MB: The tumour microenvironment as a target for chemoprevention. Nat Rev Cancer 7: 139-147, 2007.
2. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1: 27-31, 1995.
3. Folkman J and Shing Y: Angiogenesis. J Biol Chem 267: 10931-10934, 1992.
4. Bagheri-Yarmand R, Kourbali Y, Mabilat C, Morere JF, Martin A, Lu H, Soria C, Jozefonvicz J and Crepin M: The suppression of fibroblast growth factor 2/fibroblast growth factor 4-dependent tumour angiogenesis and growth by the anti-growth factor activity of dextran derivative (CMDB7). Br J Cancer 78: 111-118 1998. (Pubitemid 28276779)
5. Bagheri-Yarmand R, Kourbali Y, Morere JF, Jozefonvicz J and Crepin M: Inhibition of MCF-7ras tumor growth by carboxymethyl benzylamide dextran: blockage of the paracrine effect and receptor binding of transforming growth factor beta1 and platelet-derived growth factor-BB. Cell Growth Differ 9: 497-504, 1998. (Pubitemid 28345874)
6. Bagheri-Yarmand R, Kourbali Y, Rath AM, Vassy R, Martin A, Jozefonvicz J, Soria C, Lu H and Crepin M: Carboxymethyl benzylamide dextran blocks angiogenesis of MDA-MB435 breast carcinoma xenografted in fat pad and its lung metastases in nude mice. Cancer Res 59: 507-510, 1999. (Pubitemid 29076039)
7. Bagheri-Yarmand R, Liu JF, Ledoux D, Morere JF and Crepin M: Inhibition of human breast epithelial HBL100 cell proliferation by a dextran derivative (CMDB7): interference with the FGF2 autocrine loop [corrected]. Biochem Biophys Res Commun 239: 424-428, 1997. (Pubitemid 27488979)
8. Kebers F, Lewalle JM, Desreux J, Munaut C, Devy L, Foidart JM and Noel A: Induction of endothelial cell apoptosis by solid tumor cells. Exp Cell Res 240: 197-205, 1998 (Pubitemid 28371100)
9. Emonard HP, Remacle AG, Noel AC, Grimaud JA, Stetler-Stevenson WG and Foidart JM: Tumor cell surface-associated binding site for the M(r) 72,000 type IV collagenase. Cancer Res 52: 5845-5848, 1992.
10. Noel A, Jost M and Maquoi E: Matrix metalloproteinases at cancer tumor-host interface. Semin Cell Dev Biol 19: 52-60, 2008. (Pubitemid 350235981)
11. Thyboll J, Kortesmaa J, Cao R, Soininen R, Wang L, Iivanainen A, Sorokin L, Risling M, Cao Y and Tryggvason K: Deletion of the laminin alpha4 chain leads to impaired microvessel maturation. Mol Cell Biol 22: 1194-1202, 2002. (Pubitemid 34094855)
12. Giannelli G, Falk-Marzillier J, Schiraldi O, Stetler-Stevenson WG and Quaranta V: Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science 277: 225-228 1997. (Pubitemid 27446075)
13. Lacroix M and Leclercq G: Relevance of breast cancer cell lines as models for breast tumours: an update. Breast Cancer Res Treat 83: 249-289, 2004. (Pubitemid 38264873)
14. Jaffe EA, Nachman RL, Becker CG and Minick CR: Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 52: 2745-2756, 1973.
15. Bonnefoy A, Harsfalvi J, Pfliegler G, Fauvel-Lafeve F and Legrand C: The subendothelium of the HMEC-1 cell line supports thrombus formation in the absence of von Willebrand factor and collagen types I, III and VI. Thromb Haemost. 85: 552-559 2001.
16. Enciso JM, Gratzinger D, Camenisch TD, Canosa S, Pinter E and Madri JA: Elevated glucose inhibits VEGF-A-mediated endocardial cushion formation: modulation by PECAM-1 and MMP-2. J Cell Biol 160: 605-615, 2003. (Pubitemid 36254398)
17. von Bulow C, Hayen W, Hartmann A, Mueller-Klieser W, Allolio B and Nehls V: Endothelial capillaries chemotactically attract tumour cells. J Pathol 193: 367-376, 2001. (Pubitemid 32229870)
18. 2+ concentration is increased upon breast tumor cell contact and mediates tumor cell transendothelial migration. Clin Exp Metastasis 16: 21-29, 1998. (Pubitemid 28122552)
19. Merto GR, Cella N and Hynes NE: Apoptosis is accompanied by changes in Bcl-2 and Bax expression, induced by loss of attachment, and inhibited by specific extracellular matrix proteins in mammary epithelial cells. Cell Growth Differ 8: 251-260, 1997. (Pubitemid 27068903)
20. Gui GP, Puddefoot JR, Vinson GP, Wells CA and Carpenter R: In vitro regulation of human breast cancer cell adhesion and invasion via integrin receptors to the extracellular matrix. Br J Surg 82: 1192-1196, 1995.
21. Stetler-Stevenson WG: Tissue inhibitors of metalloproteinases in cell signaling: metalloproteinase-independent biological activities. Sci Signal 1: re6, 2008.
22. Li H, Lindenmeyer F, Grenet C, Opolon P, Menashi S, Soria C, Yeh P, Perricaudet M and Lu H: AdTIMP-2 inhibits tumor growth, angiogenesis, and metastasis, and prolongs survival in mice. Hum Gene Ther 12: 515-526, 2001. (Pubitemid 32511073)
23. Nakahara H, Howard L, Thompson EW, Sato H, Seiki M, Yeh Y and Chen WT: Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasion. Proc Natl Acad Sci USA 94: 7959-7964, 1997. (Pubitemid 27343757)
24. Jiang A, Lehti K, Wang X, Weiss SJ, Keski-Oja J and Pei D: Regulation of membrane-type matrix metalloproteinase 1 activity by dynamin-mediated endocytosis. Proc Natl Acad Sci USA 98: 13693-13698, 2001. (Pubitemid 33115960)
25. Balduyck M, Zerimech F, Gouyer V, Lemaire R, Hemon B, Grard G, Thiebaut C, Lemaire V, Dacquembronne E, Duhem T et al: Specific expression of matrix metalloproteinases 1, 3, 9 and 13 associated with invasiveness of breast cancer cells in vitro. Clin Exp Metastasis 18: 171-178, 2000. (Pubitemid 32165251)
26. Nawrocki Raby B, Polette M, Gilles C, Clavel C, Strumane K, Matos M, Zahm JM, Van Roy F, Bonnet N and Birembaut P: Quantitative cell dispersion analysis: new test to measure tumor cell aggressiveness. Int J Cancer 93: 644-652, 2001. (Pubitemid 32695111)
27. Deryugina EI, Ratnikov B, Monosov E, Postnova TI, DiScipio R, Smith JW and Strongin AY: MT1-MMP initiates activation of pro-MMP-2 and integrin alphavbeta3 promotes maturation of MMP-2 in breast carcinoma cells. Exp Cell Res 263: 209-223, 2001. (Pubitemid 32989095)
28. Lewalle JM, Bajou K, Desreux J, Mareel M, Dejana E, Noel A and Foidart JM: Alteration of interendothelial adherens junctions following tumor cell-endothelial cell interaction in vitro. Exp Cell Res 237: 347-356, 1997. (Pubitemid 28027929)